Serial, Non-invasive Analysis of Exhaled Breath Condensate in Ventilated Trauma Patients
NCT ID: NCT02652247
Last Updated: 2022-08-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
110 participants
INTERVENTIONAL
2016-01-31
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Exhaled Breath Condensate Analysis in Mechanically Ventilated Patients
NCT06189924
Diaphragm Protective Ventilation in the Intensive Care Unit
NCT03527797
Reduced Ventilator-Free Days and Bacterial Colonization of Sub-Glottic Secretions
NCT02311296
Continuous Exhaled Breath Condensate pH in Mechanically Ventilated Patients
NCT00429637
The Effects of Nutritional Support of Critically Ill Patients Requiring Mechanical Ventilation
NCT00256074
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ventilated trauma patients with pneumonia
ventilated trauma patients with pneumonia
molecular analysis of exhaled breath condensate
molecular analysis of mini-bronchoalveolar lavage (BAL) aspirate
molecular analysis of bronchoalveolar lavage (BAL) aspirate
ventilated trauma patients without pneumonia
ventilated trauma patients without pneumonia
molecular analysis of exhaled breath condensate
molecular analysis of mini-bronchoalveolar lavage (BAL) aspirate
ventilated surgical ICU patients with pneumonia
ventilated surgical ICU patients with pneumonia
molecular analysis of exhaled breath condensate
molecular analysis of mini-bronchoalveolar lavage (BAL) aspirate
molecular analysis of bronchoalveolar lavage (BAL) aspirate
ventilated surgical ICU patients without pneumonia
ventilated surgical ICU patients without pneumonia
molecular analysis of exhaled breath condensate
molecular analysis of mini-bronchoalveolar lavage (BAL) aspirate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
molecular analysis of exhaled breath condensate
molecular analysis of mini-bronchoalveolar lavage (BAL) aspirate
molecular analysis of bronchoalveolar lavage (BAL) aspirate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Admitted to the Vanderbilt Trauma (TICU) and Surgical Intensive Care Units (SICU)
* Mechanically ventilated for ≥2 successive days (without planned extubation within 24 hours of enrollment)
Exclusion Criteria
* Expected survival less than 24 hours
* Anticipated extubation within 24 hours of enrollment
* Conditions limiting the subject's ability to tolerate collection of lavage specimens, including: FIO2 \> 80%; PEEP \> 16 cmH2O; Intracranial pressure \>20 cmH2O; Tracheal or mucosal bleeding; Platelet count \< 20,000 cells/uL; INR \> 2.0
* Known prisoners
* Pneumonia diagnosis at the time of ICU admission
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute of General Medical Sciences (NIGMS)
NIH
Vanderbilt University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Wonder Drake
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Addison K May, MD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
151194
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.